DE60002552T2 - Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen - Google Patents

Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen Download PDF

Info

Publication number
DE60002552T2
DE60002552T2 DE60002552T DE60002552T DE60002552T2 DE 60002552 T2 DE60002552 T2 DE 60002552T2 DE 60002552 T DE60002552 T DE 60002552T DE 60002552 T DE60002552 T DE 60002552T DE 60002552 T2 DE60002552 T2 DE 60002552T2
Authority
DE
Germany
Prior art keywords
use according
medicament
heart disease
chronic heart
bpi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60002552T
Other languages
German (de)
English (en)
Other versions
DE60002552D1 (de
Inventor
P. Brett GIROIR
J. Patrick SCANNON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Xoma Technology Ltd USA
University of Texas at Austin
Original Assignee
University of Texas System
Xoma Technology Ltd USA
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, Xoma Technology Ltd USA, University of Texas at Austin filed Critical University of Texas System
Publication of DE60002552D1 publication Critical patent/DE60002552D1/de
Application granted granted Critical
Publication of DE60002552T2 publication Critical patent/DE60002552T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60002552T 1999-01-22 2000-01-21 Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen Expired - Fee Related DE60002552T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11673699P 1999-01-22 1999-01-22
US116736P 1999-01-22
PCT/US2000/001515 WO2000043028A2 (en) 1999-01-22 2000-01-21 Method of treating chronic cardiac disease

Publications (2)

Publication Number Publication Date
DE60002552D1 DE60002552D1 (de) 2003-06-12
DE60002552T2 true DE60002552T2 (de) 2004-02-26

Family

ID=22368911

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60002552T Expired - Fee Related DE60002552T2 (de) 1999-01-22 2000-01-21 Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen

Country Status (11)

Country Link
US (3) US6509317B1 (enExample)
EP (1) EP1143996B1 (enExample)
JP (2) JP2002535282A (enExample)
CN (1) CN1353614A (enExample)
AT (1) ATE239492T1 (enExample)
AU (1) AU778001B2 (enExample)
CA (1) CA2359681A1 (enExample)
DE (1) DE60002552T2 (enExample)
MX (1) MXPA01007031A (enExample)
NZ (1) NZ513087A (enExample)
WO (1) WO2000043028A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1339424A2 (en) 2000-12-01 2003-09-03 XOMA Technology Ltd. Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
WO2010062738A1 (en) * 2008-11-03 2010-06-03 Ut-Battelle, Llc Diagnosis and treatment of congenital heart defects using nell 1
US9974759B2 (en) * 2013-05-31 2018-05-22 Indiana University Research And Technology Corporation Beta 2 adrenoceptor antagonists for treating orthostatic hypotension
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
GB201319621D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643875A (en) 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
US5578568A (en) 1994-04-22 1996-11-26 Xoma Corporation Method of treating conditions associated with intestinal ischemia/reperfusion
US5646114A (en) * 1994-07-11 1997-07-08 Xoma Corporation Anti-protozoan methods
DK0914144T3 (da) * 1996-05-10 2001-04-09 Univ Texas Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi

Also Published As

Publication number Publication date
JP2002535282A (ja) 2002-10-22
US6509317B1 (en) 2003-01-21
AU2734100A (en) 2000-08-07
DE60002552D1 (de) 2003-06-12
EP1143996A2 (en) 2001-10-17
CA2359681A1 (en) 2000-07-27
EP1143996A4 (de) 2002-04-24
US20030216312A1 (en) 2003-11-20
CN1353614A (zh) 2002-06-12
WO2000043028A9 (en) 2001-09-20
JP2007126479A (ja) 2007-05-24
AU778001B2 (en) 2004-11-11
US20060171937A1 (en) 2006-08-03
ATE239492T1 (de) 2003-05-15
MXPA01007031A (es) 2004-08-12
WO2000043028A2 (en) 2000-07-27
EP1143996B1 (en) 2003-05-07
NZ513087A (en) 2003-02-28
WO2000043028A3 (en) 2000-11-30
US7045501B2 (en) 2006-05-16

Similar Documents

Publication Publication Date Title
US5990086A (en) Therapeutic uses of BPI protein products for human meningococcemia
US5912228A (en) Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
DE69526216T2 (de) Antifungaleverfahren und mitteln
US5945399A (en) Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma
DE69433848T2 (de) Bpi-protein-produkte für definierte funktionen des reticuloendothelialen systems
JP2023539476A (ja) アネキシンａ１のｎ末端ペプチド製剤及び方法
DE60002552T2 (de) Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen
DE69718047T2 (de) Therapeutische verwendung von bpi proteineprodukten bei patienten mit zystischer fibrose
DE60008749T2 (de) Therapeutische peptide aus untersequenzen von bpi
US5990082A (en) Uses of lipopolysaccharide binding protein
HK1019856B (en) Therapeutic uses of bpi protein products for human meningococcemia

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee